OCT 02, 2020 7:00 PM PDT

Stop the Clot: A New Antibody Treatment for Thrombosis

WRITTEN BY: Tara Fernandez

Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from entering the body. However, there’s a dark side to blood clotting. A blood clot, or thrombus, that ends up in the circulation can cause a heart attack or a stroke.

Australian researchers have designed an antibody-based treatment that blocks thrombosis without the unwanted side effects of current treatments such as blood thinners and anticoagulants. This antibody, the first of its kind, targets a specific protein in the blood called Von Willebrand Factor, or VWF. The study was published in Haematologica.

Therapies to inhibit blood clotting often lead to excessive bleeding because they are not selective for “bad” blood clots, but instead stop all coagulation in the body. Moreover, they are not effective for all patients. Statistics show that four out of five patients receiving traditional antithrombotic medications continue to have cardiovascular events even during treatment.

Erik Westein from the Australian Centre for Blood Diseases at Monash University explained: “Our approach was to first identify the biological differences between normal blood clotting and pathological blood clotting, and we found that VWF changes its properties when dangerous blood clots are forming.”

"Next, we engineered an antibody that only detects and blocks this pathological form of VWF and is therefore only active when a blood clot becomes pathological.”

The team’s engineered antibody was designed to not interfere with normal blood clotting and as a result, can be administered at much higher doses compared to existing treatments.


Sources: Haematologica, Monash University.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 29, 2020
Drug Discovery & Development
Will We Have a COVID-19 Vaccine by Year-End?
JUL 29, 2020
Will We Have a COVID-19 Vaccine by Year-End?
This week, pharmaceutical companies Moderna and Pfizer launched giant Phase III 30,000-subject trials for their COVID-19 ...
SEP 21, 2020
Cell & Molecular Biology
The Hormones We Have at Birth Are Linked to Disease Throughout Life
SEP 21, 2020
The Hormones We Have at Birth Are Linked to Disease Throughout Life
New work may help explain why some autoimmune or immune-related diseases are more common in women, who are more likely t ...
OCT 01, 2020
Immunology
Immune Cells and MS: The Good, the Bad, and the Maybe
OCT 01, 2020
Immune Cells and MS: The Good, the Bad, and the Maybe
Much like electrical wires that are encased in plastic insulating sheaths, nerve cells also are also surrounded by a sim ...
OCT 13, 2020
Immunology
Why Halloween Is Extra Scary for Kids With Peanut Allergies
OCT 13, 2020
Why Halloween Is Extra Scary for Kids With Peanut Allergies
A recent study showed that there is an 85 percent spike in peanut allergy anaphylaxis cases on Halloween. The study, per ...
NOV 09, 2020
Microbiology
Fighting COVID-19 with Help From Llamas
NOV 09, 2020
Fighting COVID-19 with Help From Llamas
Camelids, which include llamas, alpacas and camels have immune systems that generate two kinds of antibodies when confro ...
NOV 25, 2020
Immunology
Another COVID-19 vaccine shows promising results!
NOV 25, 2020
Another COVID-19 vaccine shows promising results!
A week ago, another biotechnology company "Moderna" announced the preliminary results from its COVID-19 vaccin ...
Loading Comments...